About Kevin Schulman
Form D filings for Grid Therapeutics from 2018 to 2023 list Kevin Schulman as director.
Kevin Schulman first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Kevin Schulman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kevin Schulman works with at each company, as listed on that company's latest Form D.
Grid Therapeutics LLC · Form D, Jan 5, 2023
TP
Thomas Patz
Executive officer and director
EJ
Edward Patz, Jr.
CEO and director
SL
Scott Lyman
Executive officer
PP
Paolo Paoletti
Director
RP
Richard Parker
Director